MCKESSON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 564.1 USD | -0.08% |
|
+1.87% | +22.03% |
| May. 17 | JPMorgan Adjusts McKesson Price Target to $656 From $589 | MT |
| May. 16 | McKesson Seeks Acquisitions | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2025 * | 358B | Sales 2026 * | 386B | Capitalization | 73.38B |
|---|---|---|---|---|---|
| Net income 2025 * | 3.72B | Net income 2026 * | 3.9B | EV / Sales 2025 * | 0.2 x |
| Net cash position 2025 * | 320M | Net cash position 2026 * | 2.66B | EV / Sales 2026 * | 0.18 x |
| P/E ratio 2025 * |
19.3
x | P/E ratio 2026 * |
18
x | Employees | 48,000 |
| Yield 2025 * |
0.48% | Yield 2026 * |
0.52% | Free-Float | 46.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on McKesson Corporation
More recommendations
More press releases
More news
| 1 day | +1.58% | ||
| 1 week | +0.82% | ||
| Current month | +5.08% | ||
| 1 month | +7.56% | ||
| 3 months | +10.46% | ||
| 6 months | +25.39% | ||
| Current year | +21.93% |
1 week
548.73
564.87
1 month
517.82566.01
Current year
462.70566.01
1 year
373.28566.01
3 years
184.43566.01
5 years
112.60566.01
10 years
106.11566.01
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 57 | 11-12-31 |
| Director of Finance/CFO | 55 | 18-01-26 | |
Francisco Fraga
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Donald Knauss
CHM | Chairman | 73 | 14-10-19 |
Webster Dunbar
BRD | Director/Board Member | 62 | 22-03-31 |
| Director/Board Member | 66 | 22-01-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.31% | 1,085 M€ | +8.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 564.6 | +0.02% | 169 634 |
| 24-05-17 | 564.5 | +1.58% | 575,688 |
| 24-05-16 | 555.8 | +0.76% | 758,618 |
| 24-05-15 | 551.6 | -0.00% | 539,621 |
| 24-05-14 | 551.6 | -0.55% | 625,980 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
2024-06-02
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
564.5
USD
Average target price
584.1
USD
Spread / Average Target
+3.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.93% | 73.38B | |
| -1.71% | 24.13B | |
| +7.33% | 8.78B | |
| +10.34% | 8.59B | |
| -19.80% | 8.06B | |
| +14.16% | 5.26B | |
| -0.03% | 4.21B | |
| +12.70% | 4.17B | |
| -2.54% | 3.89B | |
| +24.00% | 3.71B |
- Stock Market
- Equities
- MCK Stock
